Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy.

Huang J, Zhang Y, Peng Z, Gao H, Xu L, Jiao LR, Chen M.

J Cancer Res Clin Oncol. 2013 Oct;139(10):1709-19. doi: 10.1007/s00432-013-1497-y. Epub 2013 Aug 28.

PMID:
23982274
2.
3.

Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.

Lei HJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW.

J Am Coll Surg. 2006 Oct;203(4):426-35. Epub 2006 Aug 23.

PMID:
17000385
4.

Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.

Zhang TT, Zhao XQ, Liu Z, Mao ZY, Bai L.

Clin Transl Oncol. 2016 Aug;18(8):831-40. doi: 10.1007/s12094-015-1446-0. Epub 2015 Nov 17.

PMID:
26577107
5.

Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E.

World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.

6.

LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.

Zhou L, Rui JA, Wang SB, Chen SG, Qu Q.

J Surg Res. 2010 Mar;159(1):538-44. doi: 10.1016/j.jss.2008.09.004. Epub 2008 Oct 7.

PMID:
19111323
7.

Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.

Park SK, Jung YK, Chung DH, Kim KK, Park YH, Lee JN, Kwon OS, Kim YS, Choi DJ, Kim JH.

Korean J Intern Med. 2013 Jul;28(4):428-38. doi: 10.3904/kjim.2013.28.4.428. Epub 2013 Jul 1.

8.

Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI.

Lu W, Dong J, Huang Z, Guo D, Liu Y, Shi S.

J Gastroenterol Hepatol. 2008 Dec;23(12):1874-8. doi: 10.1111/j.1440-1746.2008.05527.x.

PMID:
18752560
9.

Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.

Goh BK, Teo JY, Chan CY, Lee SY, Jeyaraj P, Cheow PC, Chow PK, Ooi LL, Chung AY.

J Surg Oncol. 2016 Jan;113(1):89-93. doi: 10.1002/jso.24099. Epub 2015 Nov 26.

PMID:
26611492
10.

Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma.

Cheng CH, Lee CF, Wu TH, Chan KM, Chou HS, Wu TJ, Yu MC, Chen TC, Lee WC, Chen MF.

World J Surg Oncol. 2011 Sep 30;9:114. doi: 10.1186/1477-7819-9-114.

12.

Prognostic influence of spontaneous tumor rupture on hepatocellular carcinoma after interval hepatectomy.

Chan AC, Dai JW, Chok KS, Cheung TT, Lo CM.

Surgery. 2016 Feb;159(2):409-17. doi: 10.1016/j.surg.2015.07.020. Epub 2015 Aug 18.

PMID:
26294087
13.

Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.

Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee HS, Lin PW, Huang GT, Sheu JC, Tsai HM, Lee PC, Chau GY, Lui WY, Lee SD, Wu JC.

J Gastroenterol Hepatol. 2005 May;20(5):765-71.

PMID:
15853992
14.

The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy.

Huang J, Xu L, Luo Y, He F, Zhang Y, Chen M.

Med Oncol. 2014 Apr;31(4):883. doi: 10.1007/s12032-014-0883-x. Epub 2014 Feb 18.

PMID:
24535607
15.

Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy.

Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, Aloia TA; International Cooperative Study Group on Hepatocellular Carcinoma.

J Gastrointest Surg. 2013 Jan;17(1):66-77; discussion p.77. doi: 10.1007/s11605-012-2005-4. Epub 2012 Sep 5.

16.

Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy.

Qiao G, Cucchetti A, Li J, Cescon M, Ercolani G, Liu G, Pinna AD, Li L, Shen F, Ren J.

Oncotarget. 2016 May 24;7(21):30408-19. doi: 10.18632/oncotarget.8149.

17.
18.

Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma.

Huang WJ, Jeng YM, Lai HS, Sheu FY, Lai PL, Yuan RH.

Langenbecks Arch Surg. 2015 Aug;400(6):725-34. doi: 10.1007/s00423-015-1329-4. Epub 2015 Aug 7.

PMID:
26250145
19.

Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.

Nanashima A, Omagari K, Tobinaga S, Shibata K, Sumida Y, Mine M, Morino S, Shibasaki S, Ide N, Shindou H, Nagayasu T.

Eur J Surg Oncol. 2005 Oct;31(8):882-90.

PMID:
15993031
20.

Family history of hepatocellulcar carcinoma is not associated with its patients' prognosis after hepatectomy.

Huang J, Zhang Y, Chen M, Huang J, Xu L, Chen M.

World J Surg Oncol. 2013 Oct 18;11:280. doi: 10.1186/1477-7819-11-280.

Supplemental Content

Support Center